Notes And Other Explanatory Information [Abstract]
| Concept |
2024-01-01 to 2024-12-31 |
|---|---|
| Notes and other explanatory information [abstract] | |
| Disclosure of accounting judgements and estimates [text block] |
4. Critical accounting estimates and judgements
|
| Disclosure of auditors' remuneration [text block] |
32. Services rendered by the audit firm
|
| Disclosure of authorisation of financial statements [text block] |
Pursuant to the Law on Companies of the Republic of Lithuania, the annual financial statements prepared by the management must be approved by the general meeting of shareholders. The shareholders of the Company have a statutory right to approve these financial statements or not to approve them and to require preparation of a new set of financial statements. The financial year of the Company and other Group companies coincides with the calendar year.
|
| Disclosure of basis of consolidation [text block] |
2.2 Consolidation
|
| Disclosure of basis of preparation of financial statements [text block] |
2.1 Basis of preparation
|
| Disclosure of borrowings [text block] |
25. Borrowings
|
| Disclosure of cash and cash equivalents [text block] |
21. Cash and cash equivalents
|
| Disclosure of cash flow statement [text block] |
30. Cash flows from operating activities
|
| Disclosure of changes in accounting policies, accounting estimates and errors [text block] |
33. Change of accounting policy for property, plant and equipment
|
| Disclosure of collateral [text block] |
As at 31 December 2024 the Group’s and the Company’s trade receivables and claim rights to future trade receivables were pledged as collateral respectively for amount not larger than EUR 20,000 thousand (2023: no larger than EUR 20,000 thousand).
|
| Disclosure of commitments [text block] |
Capital expenditure commitments
|
| Disclosure of commitments and contingent liabilities [text block] |
29. Contingent liabilities and commitments
|
| Disclosure of contingent liabilities [text block] |
Contingent liabilities
|
| Disclosure of cost of sales [text block] |
|
| Disclosure of credit risk [text block] |
(b) Credit risk
|
| Disclosure of deferred taxes [text block] |
17. Deferred income tax
|
| Disclosure of depreciation and amortisation expense [text block] |
Company
|
| Disclosure of derivative financial instruments [text block] |
The Group acquired IR/SWAP and fixed entire amount of non-current borrowings interest rate for entire period of the loan. The fair value of the derivative is EUR 82 thousand as at 31 December 2024 (2023: 241 thousand).
|
| Disclosure of dividends [text block] |
Dividends
|
| Disclosure of earnings per share [text block] |
13. Earnings per share
|
| Disclosure of employee benefits [text block] |
28. Provisions
|
| Disclosure of events after reporting period [text block] |
2.26 Events after the reporting period
|
| Disclosure of expenses [text block] |
6. Selling and marketing expenses
|
| Disclosure of expenses by nature [text block] |
10. Expenses by nature
|
| Disclosure of fair value measurement [text block] |
The fair value of borrowings is attributed to Level 2 in the fair value hierarchy.
|
| Disclosure of finance cost [text block] |
11. Finance costs
|
| Disclosure of financial instruments [text block] |
18. Loans granted
|
| Disclosure of financial risk management [text block] |
3. Financial risk management
|
| Disclosure of general and administrative expense [text block] |
7. General and administrative expenses
|
| Disclosure of going concern [text block] |
The financial statements have been prepared on a going concern basis
|
| Disclosure of government grants [text block] |
26. Deferred income
|
| Disclosure of impairment of assets [text block] |
In view of the deterioration of the economic situation of certain farmers, an impairment provision was established for certain prepayments for milk supply. As at 31 December 2024 and 2023, it amounted, respectively, to EUR 211 thousand and EUR 561 thousand.
|
| Disclosure of income tax [text block] |
12. Income tax
|
| Disclosure of information about employees [text block] |
The average number of the Company’s employees during the year ended 31 December 2024 was 718 (2023: 763). The average number of the Group’s employees during the year ended 31 December 2024 was 1,155 (2023: 1,205).
|
| Disclosure of information about key management personnel [text block] |
Compensation of key management personnel
|
| Disclosure of intangible assets [text block] |
15. Intangible assets
|
| Disclosure of interest income [text block] |
|
| Disclosure of interest income (expense) [text block] |
8. Other income
|
| Disclosure of inventories [text block] |
19. Inventories
|
| Disclosure of issued capital [text block] |
22. Share capital
|
| Disclosure of liquidity risk [text block] |
(c) Liquidity risk
|
| Disclosure of market risk [text block] |
(i) Foreign exchange risk
|
| Disclosure of material accounting policy information [text block] |
2. Accounting policies
|
| Disclosure of objectives, policies and processes for managing capital [text block] |
3.2 Capital risk management
|
| Disclosure of other operating income (expense) [text block] |
9. Other (losses)/gains
|
| Disclosure of prepayments and other assets [text block] |
|
| Disclosure of profit (loss) from operating activities [text block] |
5. Segment reporting
|
| Disclosure of property, plant and equipment [text block] |
14. Property, plant, and equipment
|
| Disclosure of related party [text block] |
31. Related-party transactions
|
| Disclosure of reserves within equity [text block] |
24. Other reserves and reserve for acquisition of treasury shares
|
| Disclosure of information about separate financial statements [text block] |
Subsidiaries in the stand-alone financial statements are accounted at cost less impairment charge. An impairment loss is recognised for the amount by which the asset’s carrying amount exceeds its recoverable amount. The recoverable amount is the higher of an asset’s ‘fair value less costs of disposal’ or ‘value in use’. The Company assesses at the end of each reporting period whether there is any indication that an impairment loss recognised in prior periods for investment in subsidiary may no longer exist or may have decreased. If any such indication exists, the Company estimates the recoverable amount of investment and reverses impairment loss, if recoverable amount significantly exceeds the carrying amount.
|
| Disclosure of subsidiaries [text block] |
|
| Disclosure of trade and other payables [text block] |
27. Trade and other payables
|
| Disclosure of trade and other receivables [text block] |
20. Trade and other receivables
|
| Disclosure of treasury shares [text block] |
23. Treasury shares
|